Helen of Troy Limited (HELE) AI Stock Analysis

Helen of Troy Limited specializes in consumer products distributed across global markets, including the United States, Canada, Europe, Asia Pacific, Latin America, the Middle East, and Africa. The company operates through three key segments: Home & Outdoor, Health & Wellness, and Beauty. Its Home & Outdoor division offers kitchen gadgets, food storage containers, coffee and tea makers, bathroom accessories, and hydration products such as insulated water bottles and travel gear. Health & Wellness provides thermometers, blood pressure monitors, air purifiers, and water filtration systems. The Beauty segment offers grooming tools, hair care products, and styling appliances. Recognized brands include OXO, Hydro Flask, Vicks, Braun, and Revlon.

Revenue declined across recent years, moving from $2.22B in FY2022 to $2.07B in FY2023, $2.01B in FY2024, $1.91B in FY2025, and $1.79B in FY2026, reflecting a 5-year revenue CAGR of -3.2%. Operating margin compressed from 12.3% in FY2022 to 6.0% in FY2026, while FY2026 net income was -$899.0M with a net margin of -50.3% and EPS of $3.54. Over the trailing twelve months, revenue was $1.83B with an operating margin of 0.5% and EPS of -$4.46. In the latest quarter ended August 31, 2026, quarterly revenue grew 2.1% year-over-year and quarterly earnings rose 24.9%.

As of August 31, 2026, Helen of Troy held $25.0M in cash and short-term investments alongside total debt of $725.4M, resulting in net debt of $700.5M. The company reported a current ratio of 1.65 and a debt-to-equity ratio of 0.85 on shareholders' equity of $853.8M. FY2026 operating cash flow reached $171.1M, supporting free cash flow of $131.9M. For FY2026, capital deployment included $39.2M in capital expenditures and $1.9M dedicated to share buybacks.

At a last close of $28.99, Helen of Troy carried a market cap of $678.1M and an enterprise value of $1.44B. The stock traded at a forward P/E of 8.5x, which is lower than the 14.3x median of its US-listed Consumer Defensive peers. Its price-to-sales of 0.4x and EV-to-EBITDA of 7.0x also compare to peer medians of 0.7x and 11.7x, respectively. The stock gained 45.9% over the past year, outperforming the 16.8% return of the S&P 500, but its 5-year return of -87.2% trailed the index return of 83.0%.

Analyst coverage consists of 1 Buy and 3 Hold ratings, with 0 Strong Buy, Sell, or Strong Sell recommendations. The mean price target of $31.67 represents a 9.2% premium over the last close of $28.99. For the current fiscal year ending February 28, 2027, consensus estimates project revenue of $1.80B and EPS of $3.89, which indicates 9.6% EPS growth. In terms of earnings execution, Helen of Troy exceeded EPS estimates in 3 of the last 4 quarters.

This page is an AI-written research summary of Helen of Troy Limited (HELE). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: HELE income statement, HELE balance sheet, HELE key metrics, HELE analyst forecast, HELE chart. See the HELE stock overview for the latest quote and news.